MA39860A - Formes polymorphes de la furazidine - Google Patents
Formes polymorphes de la furazidineInfo
- Publication number
- MA39860A MA39860A MA039860A MA39860A MA39860A MA 39860 A MA39860 A MA 39860A MA 039860 A MA039860 A MA 039860A MA 39860 A MA39860 A MA 39860A MA 39860 A MA39860 A MA 39860A
- Authority
- MA
- Morocco
- Prior art keywords
- furazidin
- polymorphic forms
- nitrofuran
- imidazolidin
- ylidene
- Prior art date
Links
- DECBQELQORZLLP-UAIOPKHMSA-N 1-[(e)-[(e)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione Chemical compound O1C([N+](=O)[O-])=CC=C1\C=C\C=N\N1C(=O)NC(=O)C1 DECBQELQORZLLP-UAIOPKHMSA-N 0.000 title abstract 3
- 229960002375 furazidin Drugs 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention concerne les formes cristallines de la furazidine (1-{[(1e,2e)-3-(5-nitrofuran-2-yl)prop-2-ène-1-ylidène]amino}imidazolidine-2,4-dione) et des procédés de préparation de celles-ci.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-14-44A LV15081B (lv) | 2014-05-29 | 2014-05-29 | Furazidīna polimorfās formas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39860A true MA39860A (fr) | 2015-12-03 |
Family
ID=53969380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA039860A MA39860A (fr) | 2014-05-29 | 2015-05-27 | Formes polymorphes de la furazidine |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3148988A1 (fr) |
| EA (1) | EA201692217A1 (fr) |
| LV (1) | LV15081B (fr) |
| MA (1) | MA39860A (fr) |
| UA (1) | UA115290C2 (fr) |
| WO (1) | WO2015181741A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990402A (en) | 1958-10-07 | 1961-06-27 | Smith Kline French Lab | Preparation of 1-aminohydantoin derivatives |
| FR1489091A (fr) | 1966-05-09 | 1967-07-21 | Clin Byla Ets | Nouvelles hydantoïnes et leur préparation |
| AU7694596A (en) | 1995-11-27 | 1997-06-19 | Lonza A.G. | Process for producing 1-aminohydantoin |
| PL185120B1 (pl) | 1997-03-17 | 2003-02-28 | Adamed Sp Z Oo | Sposób┴wytwarzania┴1-{[3-(5-nitro-2-furylo)-2-propenylideno]-amino}-2,4-imidazolidynodionu |
-
2014
- 2014-05-29 LV LVP-14-44A patent/LV15081B/lv unknown
-
2015
- 2015-05-27 EA EA201692217A patent/EA201692217A1/ru unknown
- 2015-05-27 UA UAA201611302A patent/UA115290C2/uk unknown
- 2015-05-27 MA MA039860A patent/MA39860A/fr unknown
- 2015-05-27 EP EP15753991.7A patent/EP3148988A1/fr not_active Withdrawn
- 2015-05-27 WO PCT/IB2015/053968 patent/WO2015181741A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| LV15081B (lv) | 2016-11-20 |
| LV15081A (lv) | 2015-12-20 |
| EA201692217A1 (ru) | 2017-05-31 |
| EP3148988A1 (fr) | 2017-04-05 |
| UA115290C2 (uk) | 2017-10-10 |
| WO2015181741A1 (fr) | 2015-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268625A (en) | Amino pyrimidine compounds used as SSAO inhibitors | |
| PT3534743T (pt) | Calçado, e método de preparar o mesmo | |
| ZA201906464B (en) | Crystalline forms of (s)-afoxolaner | |
| EP3185655B8 (fr) | Procédé de codage individuel de substrats métal-céramiques | |
| EP3310358A4 (fr) | Compositions et procédés pour le traitement de troubles d'utilisation de substances, d'accoutumance, et de troubles psychiatriques | |
| IL273896A (en) | Crystal forms of 3-disubstituted 1, 2, 4-oxadiazole | |
| WO2014174456A3 (fr) | Formes polymorphiques de chlorhydrate de nilotinib | |
| EP3399996A4 (fr) | Procédés d'administration d'hepcidine | |
| CA3308777A1 (en) | Crystalline forms of c21h22ci2n4o2 | |
| ZA201808014B (en) | Adenine derivatives as protein kinase inhibitors | |
| IL293192A (en) | Methods for the preparation of indolinobenzodiazepine derivatives | |
| EP3530650A4 (fr) | Forme cristalline de (r)-4-hydroxy-2-oxo-1-pyrrolidineacétamide, son procédé de préparation et son utilisation | |
| EP3323811A4 (fr) | Procédé de production d'un composé hétérocyclique contenant de l'azote et intermédiaire dudit composé hétérocyclique contenant de l'azote | |
| EP3262025A4 (fr) | Nouveaux intermédiaires pour la préparation d'inhibiteurs de la dpp-iv, procédé de préparation de ces intermédiaires et procédé de préparation d'inhibiteurs de la dpp-iv utilisant ces intermédiaires | |
| MX2019010640A (es) | Formas cristalinas de acido obeticolico. | |
| EP3216791A4 (fr) | Substance polymorphe de chlorhydrate de yonkenafil, son procédé de préparation, composition à base de ladite substance et utilisation deladite substance | |
| EP3247399A4 (fr) | Formes cristallines d'éfinaconazole | |
| EP3181556A4 (fr) | Composé micromoléculaire, son procédé de synthèse et application associée | |
| EP3277665A4 (fr) | Analogues d'indole en tant qu'antagonistes des récepteurs 5-oxo-ete et procédé d'utilisation de ceux-ci | |
| EP3344593A4 (fr) | Compositions et procédés de cimentation de puits | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| UA115290C2 (uk) | Поліморфні форми фуразидину | |
| IL265634A (en) | Novel 5-substituted imidazolylmethyl derivatives | |
| IT201700050223A1 (it) | Procedimento per la preparazione di dexlansoprazolo cristallino | |
| EP3110799A4 (fr) | Inhibiteurs hétérocycliques du canal sodique |